In search of biotech hub glory, the Big Apple lures local startups with lab space
The city that never sleeps is itching to become the city that could cure insomnia. With Boston and San Francisco maintaining their dominance as the premier hubs for developing drugs, New York City has orchestrated a scheme to entice biotech — identifying the lack of space in these desired clusters as a key impediment to growing startups.
Back in 2016, NYC mayor Bill de Blasio made a $500 million commitment to the sector over 10 years as part of his broader plan to boost job creation. As part of this initiative, called LifeSci NYC, $10 million has been set aside to support nascent biotechs by allocating them lab space.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.